Stockreport

Syros (SYRS) Up on FDA Fast Track Tag for Tamibarotene in AML [Yahoo! Finance]

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF treatment of acute myeloid leukemia (AML). The FDA's prestigious tag has been given to tamibarotene in combination with azacitidine and Roche RHHBY/ AbbVie 's ABBV drug [Read more]